Kezar Life Sciences Inc. (KZR)

5.70

-0.01 (-0.18%)

At close: Mar 03, 2025, 3:59 PM

5.70

0.00%

After-hours: Mar 03, 2025, 04:00 PM EST

Kezar Life Sciences Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16
Net Income	-101.87M	-68.24M	-54.63M	-41.74M	-35.09M	-23.17M	-8.52M	-8.99M
Depreciation & Amortization	1.07M	1.02M	1.51M	1.54M	1.3M	690K	175K	154K
Stock-Based Compensation	18.14M	14.01M	7.6M	4.94M	4.01M	1.99M	203K	128K
Other Working Capital	-1.64M	-6.27M	9K	-2.32M	-1.33M	-1.38M	-51K	-583K
Other Non-Cash Items	-3.68M	-1.18M	91K	317K	-979K	-370K	472K	979K
Deferred Income Tax	n/a	n/a	1.77M	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	4.71M	-4.46M	1.23M	-2.01M	881K	62K	30K	-1.05M
Operating Cash Flow	-81.64M	-58.85M	-42.44M	-36.95M	-29.88M	-20.79M	-8.11M	-9.76M
Capital Expenditures	-1.81M	-1.58M	-316K	-194K	-607K	-1.12M	-389K	-132K
Acquisitions	n/a	89.81K	28.13K	56.3K	-21.03K	10K	n/a	n/a
Purchase of Investments	-180.4M	-332.2M	-156.38M	-225.73M	-102.25M	-119.24M	n/a	n/a
Sales Maturities Of Investments	258.25M	242.39M	128.25M	169.42M	123.28M	36.45M	n/a	n/a
Other Investing Acitivies	5K	-89.81K	-28.13K	-56.3K	21.03K	10K	n/a	n/a
Investing Cash Flow	76.05M	-91.39M	-28.44M	-56.5M	20.42M	-83.9M	-389K	-132K
Debt Repayment	n/a	n/a	9.53M	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	638K	1.32M	2.08M	456K	n/a	n/a	49.76M	36K
Financial Cash Flow	638K	127.86M	112.58M	99.64M	272K	77.91M	49.76M	36K
Net Cash Flow	-4.96M	-22.43M	41.65M	6.28M	-9.23M	-26.86M	41.29M	-10.01M
Free Cash Flow	-83.45M	-60.42M	-42.75M	-37.14M	-30.48M	-21.91M	-8.5M	-9.89M